Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.Donate to our crowdfunder
The Department and other National Cancer Research Institute (NCRI) funding partners have jointly established two centres of research excellence, known as the NCRI prostate cancer collaboratives. The Department is meeting half the total cost of £7.4 million over five years.
The NCRI prostate cancer collaboratives are undertaking several studies relevant to the diagnosis of prostate cancer. An important outcome from the collaborative based at the Institute of Cancer Research is the recent discovery of the overactive E2F3 gene in prostate cancer tumours, which provides the potential for a test to distinguish between aggressive and non-aggressive prostate cancer cells.